NL194907B - Farmaceutische samenstellingen die furaanderivaten bevatten. - Google Patents

Farmaceutische samenstellingen die furaanderivaten bevatten.

Info

Publication number
NL194907B
NL194907B NL9101533A NL9101533A NL194907B NL 194907 B NL194907 B NL 194907B NL 9101533 A NL9101533 A NL 9101533A NL 9101533 A NL9101533 A NL 9101533A NL 194907 B NL194907 B NL 194907B
Authority
NL
Netherlands
Prior art keywords
pharmaceutical compositions
compositions containing
furan derivatives
containing furan
salt
Prior art date
Application number
NL9101533A
Other languages
English (en)
Other versions
NL194907C (nl
NL9101533A (nl
Inventor
Norman Richard Smith
Colin Roy Heppenstall
Stephen John Douglas
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NL9101533A publication Critical patent/NL9101533A/nl
Publication of NL194907B publication Critical patent/NL194907B/nl
Application granted granted Critical
Publication of NL194907C publication Critical patent/NL194907C/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
NL9101533A 1990-09-11 1991-09-10 Farmaceutische samenstellingen die furaanderivaten bevatten. NL194907C (nl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB9019875 1990-09-11
GB909019875A GB9019875D0 (en) 1990-09-11 1990-09-11 Pharmaceutical compositions
NO920408 1992-01-30
NO920408A NO179694C (no) 1990-09-11 1992-01-30 Farmasöytiske preparater inneholdende ranitidinderivater
EP9200498 1992-03-05
PCT/EP1992/000498 WO1993017679A1 (en) 1990-09-11 1992-03-05 Compositions containing ranitidine/bismuth carboxylates salts

Publications (3)

Publication Number Publication Date
NL9101533A NL9101533A (nl) 1992-04-01
NL194907B true NL194907B (nl) 2003-03-03
NL194907C NL194907C (nl) 2003-07-04

Family

ID=47884627

Family Applications (1)

Application Number Title Priority Date Filing Date
NL9101533A NL194907C (nl) 1990-09-11 1991-09-10 Farmaceutische samenstellingen die furaanderivaten bevatten.

Country Status (33)

Country Link
US (1) US5456925A (nl)
EP (1) EP0558779B1 (nl)
JP (1) JPH0692849A (nl)
KR (1) KR100196308B1 (nl)
AT (2) AT405134B (nl)
AU (2) AU640816B2 (nl)
BE (1) BE1005115A5 (nl)
BG (1) BG61931B1 (nl)
CA (1) CA2050970C (nl)
CH (1) CH683068A5 (nl)
CY (1) CY1988A (nl)
DE (2) DE4130061A1 (nl)
DK (1) DK159191A (nl)
ES (1) ES2072647T3 (nl)
FI (1) FI944047A (nl)
FR (1) FR2666508B1 (nl)
GB (2) GB9019875D0 (nl)
HK (1) HK60894A (nl)
HU (1) HU211846A9 (nl)
IE (1) IE65049B1 (nl)
IL (1) IL99428A (nl)
IT (1) IT1249696B (nl)
MX (1) MX9101009A (nl)
NL (1) NL194907C (nl)
NO (1) NO179694C (nl)
NZ (1) NZ239731A (nl)
OA (1) OA10093A (nl)
RO (1) RO112084B1 (nl)
RU (1) RU2108097C1 (nl)
SE (1) SE509694C2 (nl)
SK (1) SK279591B6 (nl)
WO (1) WO1993017679A1 (nl)
ZA (1) ZA917176B (nl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
DE69228738D1 (de) * 1991-12-06 1999-04-29 Glaxo Group Ltd Zusammensetzungen zur Behandlung von entzündlichen Zuständen oder Analgesie, die Ranitidin Wismuth Citrat und einen NSAID enthalten
GB9127150D0 (en) * 1991-12-20 1992-02-19 Smithkline Beecham Plc Novel treatment
GB9501560D0 (en) 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
US6117412A (en) * 1995-01-26 2000-09-12 Nycomed Imaging As Non-cluster type bismuth compounds
WO2000010562A1 (fr) * 1998-08-18 2000-03-02 Leonidov Nikolai B Forme physiquement stable et amorphe aux rayons x de ranitidine d'hydrochlorure ayant une action anti-ulcere accrue, et procede de production
EP1104673A1 (en) * 1999-11-30 2001-06-06 Bayer Classics A hydrogen carbonate-containing, desintegrating agent-free pharmaceutical composition
KR100412290B1 (ko) * 2001-11-27 2003-12-31 주식회사 동구제약 라니티딘 함유 현탁제 조성물 및 그의 제조방법
US20060100271A1 (en) * 2004-11-08 2006-05-11 Keith Whitehead Stabilized aqueous ranitidine compositions
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
WO2010011522A1 (en) * 2008-07-21 2010-01-28 Albemarle Corporation High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
CN115697354A (zh) * 2020-06-01 2023-02-03 香港大学 用于治疗sars-cov-2感染的组合物和方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4608257A (en) * 1984-01-03 1986-08-26 Board Of Regents For Oklahoma State University Composition and method for treating heat stress
GB8629781D0 (en) * 1986-12-12 1987-01-21 Glaxo Group Ltd Pharmaceutical compositions
EP0282132B1 (en) * 1987-03-09 1992-09-30 The Procter & Gamble Company Compositions and their use for treating gastrointestinal disorders
DE3710462A1 (de) * 1987-03-30 1988-10-13 Heumann Pharma Gmbh & Co Pharmazeutische zubereitung zur behandlung von erkrankungen des magen-darm-traktes
FR2633181B1 (fr) * 1988-06-24 1992-01-10 Glaxo Lab Sa Composition pharmaceutique a base de ranitidine et son procede de preparation
CH679582A5 (nl) * 1988-07-18 1992-03-13 Glaxo Group Ltd
ES2040307T3 (es) * 1988-10-08 1993-10-16 Dr. R. Pfleger Chemische Fabrik Gmbh Procedimiento para producir un preparado medicamentoso liquido que contiene bismuto.
AU641903B2 (en) * 1988-10-26 1993-10-07 Glaxo Group Limited Carboxylic acid derivatives
US5013560A (en) * 1989-03-17 1991-05-07 The Procter & Gamble Company Microbially-stable bismuth-containing liquid pharmaceutical suspensions
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
CY1988A (en) 1997-09-05
WO1993017679A1 (en) 1993-09-16
US5456925A (en) 1995-10-10
GB9119284D0 (en) 1991-10-23
NL194907C (nl) 2003-07-04
NO920408L (no) 1993-08-02
ITRM910673A0 (it) 1991-09-10
EP0558779A1 (en) 1993-09-08
RU2108097C1 (ru) 1998-04-10
NO179694B (no) 1996-08-26
SE509694C2 (sv) 1999-02-22
SK279591B6 (sk) 1999-01-11
AT405134B (de) 1999-05-25
AU640816B2 (en) 1993-09-02
FI944047A0 (fi) 1994-09-02
NO920408D0 (no) 1992-01-30
RO112084B1 (ro) 1997-05-30
IT1249696B (it) 1995-03-09
CA2050970A1 (en) 1992-03-12
FI944047A (fi) 1994-09-02
ES2072647T3 (es) 1995-07-16
DK159191D0 (da) 1991-09-10
ATA180191A (de) 1998-10-15
DK159191A (da) 1992-03-12
HU211846A9 (en) 1995-12-28
KR100196308B1 (ko) 1999-06-15
NL9101533A (nl) 1992-04-01
SK106094A3 (en) 1995-02-08
ATE122883T1 (de) 1995-06-15
BG99021A (bg) 1995-06-30
GB2248185B (en) 1994-02-02
BG61931B1 (bg) 1998-10-30
OA10093A (en) 1996-12-18
SE9102604L (sv) 1992-03-12
GB9019875D0 (en) 1990-10-24
DE4130061A1 (de) 1992-03-12
NO179694C (no) 1996-12-04
JPH0692849A (ja) 1994-04-05
NZ239731A (en) 1993-10-26
ZA917176B (en) 1992-06-24
GB2248185A (en) 1992-04-01
AU8375791A (en) 1992-03-19
CA2050970C (en) 2002-11-19
EP0558779B1 (en) 1995-05-24
BE1005115A5 (fr) 1993-04-27
FR2666508A1 (fr) 1992-03-13
IE913191A1 (en) 1992-04-22
IL99428A (en) 1996-06-18
HK60894A (en) 1994-07-08
SE9102604D0 (sv) 1991-09-10
FR2666508B1 (fr) 1994-02-18
DE69202696D1 (de) 1995-06-29
IE65049B1 (en) 1995-10-04
AU1334792A (en) 1993-10-05
CH683068A5 (fr) 1994-01-14
KR920005984A (ko) 1992-04-27
ITRM910673A1 (it) 1993-03-10
IL99428A0 (en) 1992-08-18
MX9101009A (es) 1992-05-04

Similar Documents

Publication Publication Date Title
DE59010810D1 (de) Arzneimittel enthaltend als Wirkstoff R-alpha-Liponsäure oder S-alpha-Liponsäure
NL194907B (nl) Farmaceutische samenstellingen die furaanderivaten bevatten.
DE3880047D1 (de) Zusammensetzung eines zusatzes.
SE8902288L (sv) Farmaceutisk komposition
SE8702941L (sv) Farmaceutisk, n-acetyl-cysteininnehallande, vattenloslig komposition
SE8704952D0 (sv) Farmaceutisk komposition
IT7927748A0 (it) Derivati dell'acido 6,6'-diapopsi psicarotenedioico e relativi procedimenti di preparazione.
FI791565A (fi) Farmaceutiska sammansaettningar innehaollande prostaglandinfoereningar
GB2021409A (en) Pharmaceutical composition
IT8620208A0 (it) Eteri del 7-ossabicicloeptano sostituiti quali analoghi di prostaglandine e relative composizioni farmaceutiche.
DE3865642D1 (de) Pharmazeutische zubereitung zur cholelitholyse.
MX15990A (es) Derivados de acido 3-pirrolidiniltio-1- azabiciclo(3.2.0)hept-2-eno-2-carboxilico, su obtencion y usos.
JPS53149939A (en) Novel benzyl alcohol derivatives and their preparation
DK420187D0 (da) Oxiran-pseudooligosaccharider, deres fremstilling og anvendelse
JPS5331665A (en) Optical active chlorophenylalanine. acylphenylglycine salt and its preparation
JPS537697A (en) 3-phenylhydantoic acid derivatives, their preparation and nonmedical fungicides containing the same as active constituents
DK163661C (da) 2,5-pyrrolidindionderivater og farmaceutisk acceptable syreadditionssalte deraf
IT7830125A0 (it) Associazione di antibiotici caratterizzata da diminuita tossicita', e composizioni farmaceutiche relative.
JPS5283517A (en) Novel derivatives of antibiotics xk-62-2
FR2191842A2 (en) Insecticidal compsns contg thiapyrans - 4-(4'-methyl-3'-hexenyl) 5,6-dihydro-2-H-thiapyran and its 5-oxide have juvenile hormone activity
GB2162746A (en) Antiacidotic medicinal agent

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V1 Lapsed because of non-payment of the annual fee

Effective date: 20070401